Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Deloitte
Chubb
Daiichi Sankyo
UBS
McKinsey
Citi
Fish and Richardson
Healthtrust
McKesson

Generated: February 21, 2018

DrugPatentWatch Database Preview

Estropipate - Generic Drug Details

« Back to Dashboard

What are the generic sources for estropipate and what is the scope of estropipate patent protection?

Estropipate
is the generic ingredient in seven branded drugs marketed by Pharmacia And Upjohn, Barr, Duramed Pharms Barr, Mylan, Watson Labs, Watson Labs Teva, and Sun Pharm Inds Inc, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for estropipate. Three suppliers are listed for this compound.
Summary for estropipate

US Patents and Regulatory Information for estropipate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn OGEN 5 estropipate TABLET;ORAL 083220-004 Approved Prior to Jan 1, 1982 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Barr ESTROPIPATE estropipate TABLET;ORAL 040135-003 Nov 27, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn OGEN 1.25 estropipate TABLET;ORAL 083220-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Barr ESTROPIPATE estropipate TABLET;ORAL 040135-002 Nov 27, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Duramed Pharms Barr ESTROPIPATE estropipate TABLET;ORAL 040296-002 Nov 1, 1999 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Duramed Pharms Barr ESTROPIPATE estropipate TABLET;ORAL 040296-003 Nov 1, 1999 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Barr ESTROPIPATE estropipate TABLET;ORAL 040135-001 Nov 27, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Duramed Pharms Barr ESTROPIPATE estropipate TABLET;ORAL 040296-001 Nov 1, 1999 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan ESTROPIPATE estropipate TABLET;ORAL 040359-003 Aug 26, 1999 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan ESTROPIPATE estropipate TABLET;ORAL 040359-002 Aug 26, 1999 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Deloitte
Covington
Chinese Patent Office
Baxter
Merck
Johnson and Johnson
Accenture
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot